Product Images Teriparatide
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 26 images provide visual information about the product associated with Teriparatide NDC 47781-652 by Alvogen, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
carton - carton
This is a description of Teriparatide Injection, which contains 250 mcg teriparatide, 0.41 mg glacial acetic acid, 0.10 mg sodium acetate, 45.4 mg mannitol, 3 mg metacresol, and water for injection. The recommended dosage is 20 mcg teriparatide once a day. The injection should be kept in the refrigerator, and it should not be frozen. The medication is for subcutaneous use only. The user is advised to read the User Manual before injecting and to discard the unused portion 28 days after first use. The prescription information and device User Manual are provided in the carton.*
figure-1 - figure 1
This is information on a clinical trial involving teriparatide and a placebo. The rest of the text contains errors and is not readable.*
ifu-fig-a - ifu fig a
Teriparatide Injection is a medical device that requires needles, not included with the product. It is recommended to use Becton, Dickinson and Company pen needles with gauges from 29 to 31. The device has a white outer needle cover, an inner needle cover, a paper tab, a teal body, an instruction window, and a black injection button, as shown in Figure A.*
ifu-fig-b - ifu fig b
ifu-fig-c - ifu fig c
ifu-fig-d - ifu fig d
ifu-fig-e-f - ifu fig e f
ifu-fig-g - ifu fig g
ifu-fig-h - ifu fig h
ifu-fig-i - ifu fig i
The text provided is not available, as it consists of only a few product names and a partial figure reference.*
ifu-fig-j - ifu fig j
ifu-fig-k - ifu fig k
ifu-fig-l - ifu fig l
ifu-fig-m - ifu fig m
ifu-fig-n - ifu fig n
ifu-fig-o - ifu fig o
ifu-fig-p-q - ifu fig p q
ifu-fig-r - ifu fig r
ifu-fig-s - ifu fig s
ifu-fig-t - ifu fig t
ifu-fig-u - ifu fig u
ifu-fig-v - ifu fig v
ifu-important-info - ifu important info
ifu-ts-problem-a - ifu ts problem a
pen-label - pen label
This is a description of Teriparatide Injection, a prescription-only medication contained in a single-patient-use pen. The medication contains 620 mcg/2.48 mL (250 mcg/mL) and should be administered subcutaneously in 20 mcg doses. The User Manual should be read before use, and the medication should not be transferred to a syringe. Each pen can deliver 28 doses and should be thrown away after 28 days of use. The medication should be refrigerated and not frozen. It is distributed by Alvogen, Inc. in Morristown, NJ, USA.*
amino-acid-sequence - teriparatide
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.